0.25 / 0.82 %
41.50 %
Close in GBXToday's changeShares traded1 year changeBeta
Data delayed at least 15 minutes, as of Apr 29 2016 16:46 BST.
IMM:LSE is traded on the London Stock Exchange Alternative Investment Market (Aim)


On Friday, ImmuPharma PLC (IMM:LSE) closed at 30.13, 57.72% above the 52 week low of 19.10 set on Dec 04, 2015.

52-week range
Dec 04 2015
Apr 29 2015
Day high30.45
Day low29.31
Previous close30.38
Average volume252.29k
Shares outstanding121.78m
Free float71.68m
P/E (TTM)--
Market cap36.69m GBP
EPS (TTM)-0.0296 GBP
Data delayed at least 15 minutes, as of Apr 29 2016 16:46 BST.
Last IC View
The last IC recommendation on ImmuPharma PLC shares was Buy at 81.00 on 04 Oct 2010
Read the full article

RNS Company announcements

Notice of Results
Holding(s) in Company
First European Site Opens - Patient Recruitment
Holding(s) in Company
Holding(s) in Company

Comparative analysis

Past 90 days
1 week1 month6 months1 year5 years
ImmuPharma PLC+15.87 %+15.87 %+15.87 %-41.50 %-62.98 %
FTSE 100 IDX-1.09 %+2.23 %-1.87 %-10.14 %+2.83 %
GB/HEALTH CARE-1.60 %+1.95 %-1.99 %-10.03 %+24.06 %
GB/PHARMACEUTICALS-1.82 %+2.17 %-2.44 %-10.81 %+22.69 %
Data delayed at least 15 minutes, as of Apr 29 2016 16:46 BST.
© Thomson Reuters Click for restrictions.

All markets data located on is subject to the FT Terms & Conditions.

All content on is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.

Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.